Federal contract award
HHSN26100001
IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | HHSN261201500047I |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $11.6K |
| Current contract value | $11.6K |
| Potential contract value / ceiling | $11.6K |
| Start date | Sep 29, 2015 |
| Current end date | Sep 28, 2018 |
| Potential end date | May 30, 2021 |
| Latest award activity | May 24, 2022 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 24, 2022 | P00005 | $-30.3K | DE-OBLIGATION OF FUNDS FROM FY2017 EXPIRING LINES. |
| Apr 30, 2021 | P00004 | $-233.0K | DE-OBLIGATION OF FUNDS FROM FY2016 EXPIRING LINES. |
| Jan 18, 2018 | 3 | $-325.2K | IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC) THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE UNUSED FY15 FUNDS ON LINE ITEM 0001. |
| Sep 13, 2017 | 2 | $30.3K | IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC)THE PURPOSE OF THIS MODIFICATION IS TO ADD AND FULLY FUND LINE ITEM 0003, AND EXTEND THE PERIOD OF PERFORMANCE. |
| Aug 22, 2016 | 1 | $244.5K | IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC) |
| Sep 29, 2015 | 0 | $325.2K | IGF::OT::IGF TISSUE SOURCE SITE (TSS) FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC) |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.